Search for: "Eli Lilly & Co." Results 681 - 700 of 1,009
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Appeals Court Confirms Patent Act Section 112’s Separate Written Description Requirement
26 Mar 2010, 4:15 am by admin
Eli Lilly & Co., Fed. [read post]
US Law Watch - http://www.uslawwatch.com
Federal Circuit Confirms Written Description Requirement in Ariad
25 Mar 2010, 1:43 pm by Sheppard Mullin
Eli Lilly & Co., 119 F.3d 1559, 1568-69 (Fed. [read post]
Intellectual Property Law Blog - http://www.intellectualpropertylawblog.com/
Ariad En Banc: Written Description Requirement Is Separate From Enablement
24 Mar 2010, 11:54 am by Stephen Albainy-Jenei
Eli Lilly (08-1248). [read post]
Patent Baristas - http://www.patentbaristas.com
Enabling Written Description
24 Mar 2010, 11:33 am
Ariad sued Eli Lilly over 6,410,516. [read post]
Patent Prospector - http://www.patenthawk.com/blog/
Pharma & Biotech Global Week in Review 24 March 2010 from IP Think Tank
24 Mar 2010, 4:45 am
Eli Lilly & Co. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Not Losing the Forest for the Trees: Newman Concurs in Ariad
23 Mar 2010, 1:31 pm by Eric Guttag
Eli Lilly & Co. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
Federal Circuit Invalidates Harvard and MIT's Patent For NF-kB Gene Expression
23 Mar 2010, 6:00 am by Maxwell Kennerly
Eli Lilly and Co., pp. 12, 26. [read post]
Litigation and Trial - Max Kennerly - http://www.litigationandtrial.com/
Federal Circuit Court of Appeals Holds There are Separate Enablement and Written Description Requirements for Patents
22 Mar 2010, 9:15 pm by Patrick Richards
Eli Lilly and Co. [read post]
Richards Patent Law - http://www.richardspatentlaw.com
Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co. (Fed. Cir. 2010) (en banc)
22 Mar 2010, 8:52 pm by Patent Docs
Eli Lilly & Co. is good law. [read post]
Patent Docs - http://www.patentdocs.org/
Federal Circuit Holds That Patent Act Includes Separate Written Description Requirement
22 Mar 2010, 12:17 pm by Matt Osenga
Eli Lilly and Co. [read post]
Inventive Step - http://inventivestep.net
Federal Circuit Confirms that Patents Must Meet Both the Written Description and Enablement Requirements of Section 112.
22 Mar 2010, 8:44 am by Dennis Crouch
Eli Lilly and Co. [read post]
Patently-O - http://www.patentlyo.com/patent/
Pharma & Biotech Global Week in Review 17 March 2010 from IP Think Tank
18 Mar 2010, 2:30 am
(Patent Docs) (GenericsWeb) (patentcircle) Temodar (Temozolomide) – US: Teva announces parties to patent litigation regarding Barr’s US generic Temodar have entered into agreement pending resolution of Schering’s appeal to CAFC over ‘291 patent unenforceability finding (SmartBrief) Trilipix (Fenofibrate) – US: Impax Laboratories confirms challenge to Abbott and Fournier’s listed patent relating to Trilipix delayed-release capsules, 135 mg and 45 mg (SmartBrief)… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Learned Intermediary Causation – Lights Out In Georgia And A Texas Two-Step
11 Mar 2010, 12:23 pm by Beck, et al.
Eli Lilly & Co., 536 F. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Courts - Per settlement, Eli Lilly to add ethics watchdogs
8 Mar 2010, 10:26 am by Marcia Oddi
Some quotes:Eli Lilly and Co. has agreed to add four... [read post]
The Indiana Law Blog - http://indianalawblog.com/
Mary Pat Thynge: "Expected" Change in Federal Circuit Precedent Cannot Control JMOL Inquiry
26 Feb 2010, 12:59 pm by Andrew A. Lundgren
Eli Lilly & Co. and that the Federal Circuit's forthcoming decision in that case may alter the scope and purpose of the written description requirement. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
$18.5 Million Settlement for Illegal Off-Label Marketing of Anti-Psychotic Drug
24 Feb 2010, 11:20 am by mcarzima@imediainc.com
Eli Lilly & Co. has agreed to pay $18.5 million to the State of Arkansas to settle a lawsuit alleging that the company engaged in “illegal and fraudulent off-label marketing of Zyprexa,” an anti-psychotic drug. [read post]
Quitam Help - http://www.quitamhelp.com/
Federal Circuit's En Banc Review of Written Description Requirement Does Not Constitute "Intervening Change" or Alter "Existing Standards"
24 Feb 2010, 6:40 am by The Docket Navigator
Eli Lilly & Co., Fed. [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Pharma & Biotech Global Week in Review 24 Feb 2010 from IP Think Tank
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Pharma & Biotech Global Week in Review 24 Feb 2010 from IP Think Tank
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
What To Do With Un-Preempted Fraud On The FDA Claims
18 Feb 2010, 10:34 am by Beck, et al.
Because those are federal statutes, they can’t be “preempted” the way state-law claims were in Buckman Co. v. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/